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CASE SUMMARY 
- 58-year-old Chinese female with clinically silent hemoglobinopathy 
- Normal glucose tolerance: fasting plasma glucose 5.6mmol/L, plasma glucose two 
hours after 75g glucose loading 5.98mmol/L 
- Abnormally low, implausible glycated hemoglobin (HbA1c) results: 2.0%, 3.6% 
(16mmol/mol) on retesting 
- Normal hemoglobin level with increased turnover: hemoglobin 136g/L, reticulocyte 
percentage 6.53% 
- High-performance liquid chromatography (HPLC) indicated an abnormal peak  
- Heterozygous mutation in the HBB gene: c.242T>A, Leu81His 
- Same mutation and consistent phenotype in the daughter of the proband 
- HbA1c values estimated by HPLC is unreliable in patients with hemoglobinopathies, 
but visual inspection of the chromatogram can be used to identify hemoglobinopathies 
 
CASE NARRATIVE  
A 58-year-old woman presented with elevated fasting plasma glucose (FPG) found in a 
medical check-up. She was asymptomatic and clinical examination was normal apart from 
slight sclera jaundice. The 75-g oral glucose tolerance test (OGTT) showed FPG of 
5.6mmol/L and 2-hour postprandial plasma glucose of 5.98mmol/L. The glycated 
hemoglobin (HbA1c) taken at the same visit was 2.0% (value unavailable in the International 
Federation of Clinical Chemistry [IFCC] unit, assayed by the Tosoh G8 analyzer), and was 
3.6% (16mmol/mol) on retesting (assayed by the Bio-Rad D-10 TM analyzer). The 
synchronous glycated albumin (GA) was 11.59%. Her other blood results were: hemoglobin  
(Hb) 136g/L, red blood cell (RBC) count 4.35×1012/L, mean corpuscular volume 98.9fL 
(normal range, 82-100), mean corpuscular hemoglobin 31.3pg (normal range 27-34), and 
mean corpuscular haemoglobin concentration 316g/L (normal range 316-354). Further 
investigations showed elevated reticulocytes, elevated serum indirect bilirubin (indirect 
bilirubin: 26.9μmol/L, normal range <20; direct bilirubin: 12.6μmol/L, normal range <8.8; 
total bilirubin: 39.5μmol/L, normal range 5-28), normal transaminases, and negative fecal 
occult blood test. Haptoglobin was significantly decreased (<58.3mg/L) and methemoglobin 
reduction test was 7.7%, indicating hemolysis. The direct Coombs test was negative, and 
glucose-6-phosphate dehydrogenase activity was normal. Hb electrophoresis revealed two 
abnormal bands (assayed by Sebia CAPILLARYS 2), so hemoglobinopathy was suspected. 
Gene sequencing identified a heterozygous mutation (c.242T>A, Leu81His) in the HBB gene 
(1). During the family screening, the daughter of the proband was found to have normal 
blood glucose, decreased HbA1c (3.9%, 19mmol/mol) with abnormal bands on Hb 
electrophoresis tracing, and the same mutation (pedigree presented as Supplemental Figure 
S1). GA was used to monitor the patient’s glucose level afterward. 
 
When reviewing the case, we further requested the high-performance liquid chromatography 
(HPLC) chromatogram of this patient, in which an abnormal peak was presented (arrowed, 
Figure 1A) and was reported as the variant window. This indicated the capability of HPLC 
chromatograms in identifying unexpected variants. The HPLC chromatogram of the patient’s 
husband was presented as normal control (Figure 1B, both assayed by the Bio-Rad D-10 TM 
analyser). 
 
HbA1c is widely used as an independent diagnostic criterion for diabetes and as a monitor for 
glycemic control (2-4). However, under several circumstances, HbA1c by itself is not able to 
accurately reflect the plasma glucose level (5, 6). International guidelines have been calling 
clinicians’ attention to several comorbid conditions when HbA1c is unreliable, such as 
hemoglobinopathy and hemolytic anemia (2). In the presented case, an increased erythrocyte 
turnover and shortened RBC lifespan resulted in the abnormally decreased HbA1c reading. 
The majority of assay methods certified by the National Glycohemoglobin Standardization 
Program (NGSP) are not affected by common Hb traits (7), but if an Hb variant is detected, 
additional workup to further characterize the Hb variant may be necessary, and results should 
be correlated with complete blood count data and with clinical findings.  
 
HPLC is one of the common assays for HbA1c measurement (8), and abnormal HPLC 
chromatograms may inform clinicians and laboratory staff of potential interferences. In the 
presented case, the HPLC chromatogram was requested post hoc because of the extremely 
abnormal HbA1c value, but could be easily overlooked if the hemoglobin variant caused only 
mild interference. Although the necessity of presenting chromatograms routinely to clinicians 
needs further discussion, it is acknowledged that when measuring HbA1c by a 
chromatographic technique, visual inspection of chromatograms prior to reporting of HbA1c 
results is warranted, especially when there is discordance between HbA1c and other clinical 
data. 
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Figure 1. Chromatograms of glycated hemoglobin (HbA1c) tests. 
1A. High-performance liquid chromatography (HPLC) chromatogram of the proband. Arrow 
indicated the abnormal peak. The glycated hemoglobin (HbA1c) measured was 3.6% 
(16mmol/mol). 
1B. HPLC chromatogram of husband of the proband as normal control. The glycated 
hemoglobin (HbA1c) measured was 6.4% (47mmol/mol). 
 
 
Supplementary Figure S1. Pedigree of the family.  
Arrow indicated the proband. 
 
 
 
